Spruce Biosciences, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -1.7% | +3,371.5% | -22.3% | -32.3% | +21.4% | -56.5% | +17.3% | |
| – | -2.5% | +3,347.9% | -42.7% | -9.0% | +22.2% | -56.7% | +17.9% | |
| – | -4.6% | +3,904.8% | -72.8% | -42.7% | +293.4% | -59.8% | +26.2% | |
| – | -4.6% | +3,904.8% | -43.4% | -11.1% | +21.8% | -59.8% | +26.2% | |
| – | – | – | -9.7% | -13.5% | – | – | – | |
| – | +56.5% | -61.9% | +12.3% | +13.5% | +59.9% | -40.3% | -35.9% | |
| – | +59.1% | +126.9% | -9.1% | +40.3% | +96.6% | -37.7% | -33.8% | |
| – | – | +123.9% | -87.2% | +389.2% | +6.4% | +1.7% | -83.4% | |
| – | -18.3% | +93.2% | -22.2% | -49.5% | +133.7% | -61.1% | -27.2% | |
| – | – | -39.8% | +153.8% | -32.5% | -47.9% | -92.8% | – | |
| – | – | – | -25.5% | -38.5% | +11.7% | -62.3% | +47.5% | |
| – | – | – | – | – | – | – | – | |
| – | +2,812.5% | +4.5% | +0.4% | +0.7% | -18.2% | +7.2% | +42.9% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.